Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Comment by M101on Sep 05, 2023 10:41am
89 Views
Post# 35619762

RE:RE:RE:RE:Financing Was Obvious and Inevitable

RE:RE:RE:RE:Financing Was Obvious and Inevitable How did the word conspiracy get into this thread? I haven't read anyone here alleging that insiders coordinated illegal actions, or even that such would be needed to achieve the result seen.

All it would take to knock the price down from $6 to $2 is a rumour that $2 was the target price of the only interested investor group, and then let the market do what it does.   The source of this or similar rumour is what I mean in agreement with Farmer's "monkey business".   
And then the question is regarding the competence and motivation of the BOD, not the motivation of the placees which is obvious. 

As for the big trading day, I find it hard to believe that there was so much buy side interest without some other well placed rumour, like maybe an analyst upgrade, and the same party would benefit by planting both rumours. 

As for my naked short comments, I didn't allege that happened, rather I asked if that would be the point of an investor complaint to the SEC, precisely because I don't believe the share dump was coming from insiders for whom it would be a documented trading violation.  














<< Previous
Bullboard Posts
Next >>